✦ LIBER ✦

Effect of Tissue-type Plasminogen Activator on the Fibrinolytic System

Book ID: 120461864
Publisher: Springer-Verlag
Year: 1985
Weight: 213 KB
Volume: 484
Category: Article
ISSN: 0156-2703
DOI: 10.1007/BF03305411

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of oxidants on proteases of the f

Effect of oxidants on proteases of the fibrinolytic system: Possible role for methionine residues in the interaction between tissue type plasminogen activator and fibrin

✍ T.W. Stief; E. Martin; J. Jimenez; J. Digón; J.M. Rodriguez 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 689 KB

Initiation of a fibrinolytic system in h

Initiation of a fibrinolytic system in hepatic resection: The roles of tissue-type plasminogen activator and plasminogen activator inhibitor-1

✍ Mitsuo Shimada; Takashi Matsumata; Kazuharu Yamamoto; Hidetoshi Itasaka; Akinobu 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 426 KB

Systemic fibrinolytic effect of pulse sp

Systemic fibrinolytic effect of pulse spray thrombolysis with tissue-type plasminogen activator (rt-PA)

✍ S.W. Yusuf; J. Westby; P.W. Wenham; B.R. Hopkinson; G.S. Makin 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 296 KB

The effect of the relationship between t

The effect of the relationship between tissue-type plasminogen activator and plasminogen activator inhibitor type 1 on tissue-type plasminogen activator activity in insulin-dependent diabetes mellitus

✍ B. Myrup; P. Rossing; T. Jensen; J. Gram; C. Kluft; J. Jespersen 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Bispecific Monoclonal Antibodies Increas

Bispecific Monoclonal Antibodies Increase the Fibrin-specific Fibrinolytic Activity of Tissue-type Plasminogen Activator (tPA) and Urokinase-type Plasminogen Activator (uPA)

✍ R. BOS; W. NIEUWENHUIZEN 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Effect of oral defibrotide on tissue-pla

Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance

✍ F. Violi; D. Ferro; M. Saliola; C. Quintarelli; S. Basili; F. Balsano 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 491 KB

Defibrotide, a polydeoxyribonucleotide of mammalian origin, has been shown to reduce the blood level of the plasminogen activator inhibitor, and so to increase the activity of tissue plasminogen activator without any adverse effect. A randomized, double-blind, placebo-controlled study has been done